Cambridge, Massachusetts, United States Applied Genomic Technology Capital Funds appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the Cambridge. The fund was located in North America if to be more exact in United States.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Innovation Management, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Morphotek.
The increased amount of exits for fund were in 2007. The important activity for fund was in 2001. Deals in the range of 5 - 10 millions dollars are the general things for fund. The typical startup value when the investment from Applied Genomic Technology Capital Funds is 10-50 millions dollars. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are Venrock, Turnbridge Capital, Prospect Venture Partners. In the next rounds fund is usually obtained by Rock Maple Ventures, Morgenthaler Ventures, Forward Ventures.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Avansis Ventures | Clifton Forge, United States, Virginia |
| Bragiel Brothers | California, San Francisco, United States |
| Catapult Trust | - |
| Columbia Threadneedle Investments | England, London, United Kingdom |
| Egypt Ventures | Colombia, El Cairo, Valle del Cauca |
| Gaolu Ventures | - |
| H2020 | Chile, Providencia, Region Metropolitana |
| Hanying Jijin | China, Guangdong, Shenzhen |
| Ready Ventures | Central, Central Region, Singapore |
| Zhejiang Chengzhang Wenhua Guquan Touzi | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AVEO Oncology | $5M | 05 May 2005 | Cambridge, Massachusetts, United States | ||
Morphotek | $10M | 13 Aug 2001 | Exton, Pennsylvania, United States | ||
Hypnion | $10M | 06 Oct 2000 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AVEO Oncology | $5M | 05 May 2005 | Cambridge, Massachusetts, United States | ||
Morphotek | $10M | 13 Aug 2001 | Exton, Pennsylvania, United States | ||
Hypnion | $10M | 06 Oct 2000 | Massachusetts, United States |
